BMS-945429 Placebo
IM133-001
Phase 2 small_molecule completed
Quick answer
BMS-945429 Placebo for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at CSL Behring GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CSL Behring GmbH
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed